Skip to content

Commit

Permalink
tagged with disease
Browse files Browse the repository at this point in the history
  • Loading branch information
kamranmuazzam committed Dec 9, 2024
1 parent f63de5e commit 92966b7
Show file tree
Hide file tree
Showing 171 changed files with 8,199 additions and 3,180 deletions.
Empty file added journals/2024_12_10.md
Empty file.
Original file line number Diff line number Diff line change
@@ -0,0 +1,90 @@
- alias::
ICD-11_Code::
- ## Etiology
background-color:: blue
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features
background-color:: blue
- ### Signs and Symptoms
- #### Symptoms
- #### Signs
id:: 6a809090-cfec-499d-8a53-72733578865f
- Painful per-vaginal Bleeding
- Dark Colored Blood
- Anemia out of proportion to the visible blood loss
- Often associated with Pre-eclampsia
- Uterus
- disproportionately enlarged in concealed type
- May be tense, tender and rigid
- Fetal Heart Sound absent in concealed type
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis #obspw #unanswered
background-color:: blue
- ### Clinical Diagnosis #obGyn-prof-OSPE
- Lower abdominal pain
- Per vaginal bleeding
- Uterus is hard and contracted
- FHS is absent
- ### Per Vaginal Examination
- Placenta is not felt on lower segment
- Blood clots are felt
- ### Laboratory Tests
- ### Imaging Studies
- [[Abdominal Ultrasonography]] : Placenta in upper segment
- ### Differential Diagnosis
- ## Management and Treatment #obspw #unanswered #obGyn-prof-OSPE
background-color:: blue
- Bishop's scoring
- If cervix favourable
- ### Medical Treatment
- Induction of labor by ARM and oxytocin
- if cervix is unfavourable
- ### Surgical Options
- [[Caesarean Section]]
- ### Lifestyle and Dietary Recommendations
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Complications #obspw #unanswered
background-color:: blue
- ### Possible Complications #obGyn-prof-OSPE
- Acute Renal Failure
- DIC
- ### Long-term Effects
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Original file line number Diff line number Diff line change
@@ -0,0 +1,110 @@
- alias::
ICD-11_Code::
- ## Etiology
background-color:: blue
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features
background-color:: blue
- ### Signs and Symptoms
- #### Symptoms #eye-prof-card #card
deck:: #Eye
id:: a8cc2e5c-90dd-4c82-8d22-14a5a66b12bb
- Mild pain
logseq.order-list-type:: number
- Photophobia
logseq.order-list-type:: number
- Redness
logseq.order-list-type:: number
- #### Signs #eye-prof-card #card
deck:: #Eye
id:: ad1ea991-9cc3-440f-9266-3be8950f0d2e
- Visual Acuity reduced
logseq.order-list-type:: number
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis
background-color:: blue
- ### Clinical Diagnosis
- #### Classical Presentation
- #### Probable Diagnosis
- ### Laboratory Tests
- ### Imaging Studies
- ### Differential Diagnosis
- [[Acute Angle Closure Glaucoma]]
id:: 67541f2a-f920-4139-bbd2-9e23ab3a42b2
- id:: 67541f3e-5249-4a44-8402-70410e14efe4
| Topic | AAU | AACG |
|------------------|--------------------------------|--------------------------------|
| Pain and vision loss | Mild pain and gradual loss of vision | Severe pain and sudden marked loss of vision |
| Circumcilliary | Mild | Moderate to severe |
| Cornea | Mild hazy | Hazy |
| Ant. Chamber | Depth Normal | Shallow |
| Cell | +++ | +/- |
| Flare | +++ | + |
| Pupil | Constricted | Mild dilated |
| IOP | Less/Normal | Increased |
| Treatment | Steroid, Mydriatics | Anti-Glaucoma Drugs |
- ### Confirmation of Diagnosis
- ## Management and Treatment
background-color:: blue
- ### Medical Treatment
- Medications
- [[Mydriatics]] Topical [[Atropine 1% Sulphate]] [[TDS]]
logseq.order-list-type:: number
- [[Steroid]] -> Topical [[Dexamethasone]]
logseq.order-list-type:: number
- Mechanism of Action of the Medications
- [[Atropine 1% Sulphate]] #eye-prof-card #card
id:: 6755b7b7-3a46-45a7-aa9b-82898d07b7df
deck:: #Eye
- Relief Pain
logseq.order-list-type:: number
- Prevention and also breakdown of if existing Synachae
logseq.order-list-type:: number
- [[Steroid]] -> {{c1 Reduces Inflammation}} #eye-prof-card #card
deck:: #Eye
id:: 6755b7e5-3798-4191-a163-e41954f7ce45
- ### Surgical Options
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Possible Complications
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Original file line number Diff line number Diff line change
@@ -0,0 +1,103 @@
- alias::
ICD-11_Code::
- ## Etiology
background-color:: blue
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features #eye-prof-written
background-color:: blue
- ### Signs and Symptoms
- #### Symptoms #eye-prof-written #card
deck:: [[Eye]]
id:: a8ddd379-c7eb-43bf-b5c6-55cb70de2c56
- Watering
logseq.order-list-type:: number
- Pain
logseq.order-list-type:: number
- #### Signs #eye-prof-written #card
deck:: [[Eye]]
id:: 455c396b-e575-43bc-97c9-9a788db9e227
- Red tender tense swelling in medial canthus
logseq.order-list-type:: number
- Abscess in several cases
logseq.order-list-type:: number
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis
background-color:: blue
- ### Clinical Diagnosis
- #### Classical Presentation #classical-presentation
probability:: 85-95%
- Painful Swelling and redness over the lacrimal sac area(medial canthus), with history [[Epiphora]], occasional discharge for last 2 years
- **Pain** and **erythema** over the lacrimal sac region
- **Swelling** and **tenderness** in the lacrimal sac area
- **Purulent discharge** with pressure over the sac (regurgitation test)
- **Systemic symptoms** like **fever** and **malaise**
- Acute onset of symptoms (usually within **hours to days**)
- #### Probable Diagnosis
- ### Differential Diagnosis
- [[Chronic Dacryocystitis]]
check-for:: intermittent mucopurulent discharge without acute pain or systemic symptoms, history of long-term obstruction
- [[Acute Sinusitis]]
check-for:: nasal symptoms (congestion, discharge), pain in the maxillary or ethmoid sinuses, and possible post-nasal drip
- ### Confirmation of Diagnosis
probability:: +0% (85-95%)
- [[Sac Patency Test]] is difficult as it is painful
- ## Management and Treatment
background-color:: blue
- ### Medical Treatment
recurrence:: 30-50% or even higher (if persistent nasolacrimal obstruction)
- Broad Spectrum Antibiotics
- Warm compression
- ### Surgical Options
recurrence:: 5-10%
- [[DCR]]
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Possible Complications #eye-prof-written #card
deck:: [[Eye]]
id:: e901594a-f442-44c1-8dcb-52494a6b4f39
- [[Chronic Dacryocystitis]]
logseq.order-list-type:: number
- [[Lacrimal Abscess]]
logseq.order-list-type:: number
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
- SN: #eye-prof-written
Loading

0 comments on commit 92966b7

Please sign in to comment.